Text Size

Phase II Trial of Lonafarnib (a Farnesyltransferase Inhibitor) for Progeria

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2007 by Children's Hospital Boston.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborators:
Schering-Plough
Progeria Research Foundation
Information provided by:
Children's Hospital Boston
ClinicalTrials.gov Identifier:
NCT00425607
First received: January 22, 2007
Last updated: December 24, 2007
Last verified: December 2007
History of Changes
No Study Results Posted on ClinicalTrials.gov for this Study
About Study Results Reporting on ClinicalTrials.gov
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: October 2009
  Estimated Primary Completion Date: October 2009 (Final data collection date for primary outcome measure)
No publications provided by Children's Hospital Boston

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):